📰 Eric Shaff News
Eric Shaff News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Shaff. Real-time updates on events, politics, business and more.
January 9, 2024
VOWST preliminary net sales of approximately $10.4 million for the fourth quarter of 2023 Significant adoption of VOWST since commercial launch in June 2023 through year-end 2023 with 2,833...
November 5, 2023
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Kevin Mannix, Head of Investor Relations. Please go ahead. Kevin Mannix: […]
November 5, 2023
Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
August 8, 2023
– VOWSTTM is the first orally administered microbiome therapeutic FDA-approved for prevention of recurrence of C. difficile infection in adults following antibacterial treatment for recurrent CDI ...
August 8, 2023
Seres Therapeutics, Inc. (NASDAQ: MCRB) reported Q2 revenues of $126.47 million, 
June 21, 2023
Seres Therapeutics, Inc. , a leading microbiome therapeutics company, has been named to the “TIME100 Most Influential Companies,” a list of 100 companies making an extraordinary impact... | June 21, 2023
June 5, 2023
– VOWST is now available by prescription in the U.S. for adult patients following antibiotic treatment for recurrent CDI – – VOWST Voyage™ Support Program to help reduce... | June 5, 2023
June 5, 2023
Vowst™ (fecal microbiota spores, live-brpk) is now available to prevent the recurrence of Clostridioides difficile (CDI) infection in adults.
May 1, 2023
U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way of performing so-called fecal
April 30, 2023
U.S. health officials have approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way of performing so-called fecal transplants. The new treatment from Seres Therapeutics provides a simpler, rigorously tested version of&...